Pt cooperates well with the examination through an interpretor.
Fundoscopic exam reveal no papilledema.
Pertinent Results: [**2199-5-27**] 10:40AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-17.1 Bnzodzp-NEG Barbitr-NEG Tricycl-NEG [**2199-5-27**] 11:27AM BLOOD K-3.8 [**2199-5-27**] 04:44PM URINE  HOURS-RANDOM [**2199-5-27**] 04:44PM URINE  UCG-NEGATIVE [**2199-5-27**] 11:27AM   K+-3.8 [**2199-5-27**] 10:40AM   GLUCOSE-117* UREA N-17 CREAT-0.7 SODIUM-139 POTASSIUM-6.7* CHLORIDE-107 TOTAL CO2-20* ANION GAP-19 [**2199-5-27**] 10:40AM   ASA-NEG ETHANOL-NEG ACETMNPHN-17.1 bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2199-5-27**] 10:40AM   WBC-5.9# RBC-4.81 HGB-13.8 HCT-40.0 MCV-83 MCH-28.7 MCHC-34.5 RDW-12.8 [**2199-5-27**] 10:40AM   PLT COUNT-191 [**2199-5-27**] 10:40AM   PT-13.3 PTT-25.8 INR(PT)-1.2 [**2199-5-27**] 10:40AM   FIBRINOGE-271 [**2199-5-29**] 06:10AM BLOOD WBC-4.0 RBC-4.46 Hgb-12.8 Hct-38.1 MCV-85 MCH-28.8 MCHC-33.7 RDW-13.3 Plt Ct-169 [**2199-5-28**] 03:21AM BLOOD WBC-7.5 RBC-4.48 Hgb-13.1 Hct-36.6 MCV-82 MCH-29.2 MCHC-35.7* RDW-12.6 Plt Ct-186 [**2199-5-27**] 10:40AM BLOOD WBC-5.9# RBC-4.81 Hgb-13.8 Hct-40.0 MCV-83 MCH-28.7 MCHC-34.5 RDW-12.8 Plt Ct-191 [**2199-5-29**] 06:10AM BLOOD Plt Ct-169 [**2199-5-29**] 06:10AM BLOOD PT-13.5* PTT-28.3 INR(PT)-1.2 [**2199-5-28**] 03:21AM BLOOD Plt Ct-186 [**2199-5-28**] 03:21AM BLOOD PT-13.7* PTT-24.5 INR(PT)-1.2 [**2199-5-27**] 10:40AM BLOOD Plt Ct-191 [**2199-5-27**] 10:40AM BLOOD PT-13.3 PTT-25.8 INR(PT)-1.2 [**2199-5-28**] 03:21AM BLOOD Fibrino-236 [**2199-5-27**] 10:40AM BLOOD Fibrino-271 [**2199-5-29**] 06:10AM BLOOD Glucose-85 UreaN-14 Creat-0.7 Na-143 K-3.7 Cl-110* HCO3-24 AnGap-13 [**2199-5-28**] 03:21AM BLOOD Glucose-126* UreaN-16 Creat-0.7 Na-141 K-4.2 Cl-109* HCO3-20* AnGap-16 [**2199-5-27**] 10:40AM BLOOD Glucose-117* UreaN-17 Creat-0.7 Na-139 K-6.7* Cl-107 HCO3-20* AnGap-19 [**2199-5-29**] 06:10AM BLOOD Mg-1.6 [**2199-5-28**] 03:21AM BLOOD Calcium-8.8 Phos-3.8 Mg-2.0 Cholest-99 [**2199-5-28**] 03:21AM BLOOD Triglyc-43 HDL-60 CHOL/HD-1.7 LDLcalc-30 [**2199-5-28**] 03:21AM BLOOD Phenyto-19.2  Abdomen XRAY on [**2199-5-27**]: IMPRESSION: No evidence of bowel obstruction.
MRA Brain/MR [**First Name (Titles) 151**] [**Last Name (Titles) **] on [**2199-5-27**]: IMPRESSION: 1) Unremarkable MRA of the circle of [**Location (un) 431**].
Followup imaging of the brain within 6-8 weeks would be recommended along with neurologic monitoring to assess for any interval changes.
Head CT on [**2199-5-27**]: IMPRESSION: Rounded area of increased attenuation in the region of the pons with extension into the fourth ventricle.
EEG on [**2199-5-27**]: Sinus rhythm Normal ECG No previous tracing for comparison   Angiogram on [**2199-5-31**]:   Brief Hospital Course: Mrs. [**Known lastname **] is a 43F Spanish-speaking woman with history of seizures x 10 yrs (most recently on the night prior to presentation but usually occur [**12-23**]/month perimenstrually), chronic abd pain (ectopic pregnancy about 6 months ago) presents with sudden onset L facial droop, an ophthalmoplegia (Left "1 and [**12-23**]" syndrome.
Patient underwent an angiogram witch was negative however in the setting of bleeding it is difficult to completely exclude this etiology.
GI: An abdominal XRAY done which was negative for abdominal pain.
Dolasetron Mesylate 12.5 mg/0.625 mL Solution Sig: One (1) Intravenous  Q8H (every 8 hours) as needed.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Aluminum-Magnesium Hydroxide 225-200 mg/5 mL Suspension Sig: 15-30 MLs PO QID (4 times a day) as needed.
Provider: [**Name10 (NameIs) 4267**] [**Last Name (NamePattern4) 4268**], MD, PHD[**MD Number(3) **]: [**Hospital6 29**] NEUROLOGY Phone:[**Telephone/Fax (1) 657**] Date/Time:[**2199-8-6**] 2:30                                [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 46916**]  Completed by:[**2199-6-1**
